Supply of Medicines and Drugs on Bulk Purchase for Aiwan-e-Sadr Dispensary

The President's Secretariat (Personal) Islamabad invites reputable firms and suppliers for the supply of medicines and drugs on bulk purchase for the Aiwan-e-Sadr Dispensary for the financial year 2026-27. This procurement is conducted under the Single Stage Two Envelope Procedure ensuring a transparent and competitive bidding process. The tender documents can be obtained 24/7 from the Dak Inquiry Window at Aiwan-e-Sadr, Islamabad. Interested bidders must submit a 5% bid security of the quoted amount along with their technical and financial proposals. Items being procured: - Medicines / Drugs as per Annexure-A and specifications in Annexure-B The scope includes supplying medicines and drugs in accordance with the approved samples and technical specifications throughout the financial year ending 30 June 2027. Delivery will be made to the Dak Window, PS (Personal), Aiwan-e-Sadr, Islamabad as per the work order timelines. The firm must ensure replacement of expired or unsatisfactory items and comply with all terms and conditions outlined in the tender documents. Eligibility criteria require firms to have valid FBR registration, ATL status, and experience supplying medicines to public sector or autonomous bodies for the last three years. A minimum of five staff members including enrolled pharmacists is mandatory. Bidders must submit all required documents including licenses, certificates, work orders, and performance certificates as per the checklist. The deadline for submission is 1100 hrs on the closing date specified on the PPRA website, with bids to be delivered in person or via registered mail/courier to the Assistant Secretary (Admn), President Secretariat (Personal), Islamabad. Technical proposals will be opened first, followed by financial proposals of technically qualified bidders. Earnest money of unsuccessful bidders will be returned promptly. A practical tip for bidders: ensure your technical proposal is complete with all required documents and samples, as incomplete submissions will be rejected. Also, strictly adhere to the delivery timelines to avoid penalties including surcharge and blacklisting. This tender offers a significant opportunity for firms specializing in pharmaceutical supplies to serve a prestigious government entity with assured payment and clear evaluation criteria.